EMAIL US AT info@bcan.org
SUPPORT HOTLINE 888-901-2226
Donate Now

Bladder Cancer CME Program

Upcoming CME program at ASCO GU: Register Now!

Expert Exchange: Examining the Use of Checkpoint Inhibitors in Bladder Cancer

A CME dinner symposium to be held at the ASCO GU in San Francisco, February 14th, 6:30-8:30 PM PST

Activity Chair: Robert Dreicer, MD, MS, MACP, FASCO

Speakers: Andrea B. Apolo, MD, Arjun V. Balar, MD, and Ashish M. Kamat, MD, MBBS, FACS

Unable to attend the live symposium? View the Live Streaming or On-Demand webcast at www.543.ceconceptslive.comThe On-Demand webcast will be available for 30 days post-live event.

A New Paradigm in Urothelial Cancer: The Convergence of Immuno-Oncology and Urology

This activity is designed to meet the educational needs of urologists, oncologists, and other healthcare professionals who diagnose and manage urothelial cancer. The activity is available for credit from July 1, 2018 to July 1, 2019.

This free CME activity is available here.

Activity Chair: Ashish M. Kamat, MD, MBBS, FACS

Speakers

Arjun V. Balar, MD

Robert Dreicer, MD, MS, MACP, FASCO

Neal D. Shore, MD, FACS

Immunotherapy in Urothelial Cancer: Where Are We Now and Where Are We Going?

This educational activity is comprised of four primary sections, all of which seek to address a single overarching question about the clinical utility of immunotherapy in urothelial cancer—where are we now and where are we going? Led by three prominent content experts, this program will explore the current role of immunotherapy in locally advanced and metastatic urothelial cancer, including an overview of all FDA-approved agents and indications.

This free CME activity is available here.

Speakers

Arjun V. Balar, MD

Ashish M. Kamat, MD, MBBS, FACS

Neal D. Shore, MD, FACS